Grace Therapeutics GAAP EPS of -$0.91
What it means
- What to watch: The headline hangs on one number ($0.91) — one data point is a snapshot, so the trailing trend is the context it needs.
- How the stock is trading: $GRCE -1.66% in the latest session.
- Timing: It landed during trading hours — the market got to read it live, so the session move beside it may already carry the reaction.
Where the stock stands
$GRCE last changed hands at $1.78, -1.66% on the session, 66% below its 52-week high of $5.18 and 6.6% above its low of $1.67 — within a tenth of its 52-week low. Over the year it has ranged 210% from low to high: a very wide band; big swings are routine for this one, not news. These are latest-session quotes, not live prices — the live tape is on the $GRCE page.
How much coverage it is getting
In the last 30 days Wook has filed 2 stories about $GRCE — 1 of them this week. At its 30-day pace you would expect less than one a week, so this week is running well ahead of normal — something has the newsroom's attention. Across those stories 0 read bullish, 2 neutral and 0 bearish. This one reads neutral, so it sits in step with most of the run. 12 related stories from the same name or desk are listed beside this one.
The bigger picture
Earnings stories turn less on the headline numbers than on how they compare with what analysts expected, and on guidance for next quarter. A beat with weak guidance can land worse than a miss with a raised outlook — markets grade on the curve. On Wook's supply-chain scanner, Health Care reads watch today — early signs of strain worth keeping an eye on.
Coming up
$GRCE earnings in 6 days. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the hard numbers get the last word soon.
What to watch next
The $GRCE page has the full chart, the filings and the valuation model behind every figure here. Want the facts without the spin? Read how two or three outlets frame the same story — where they agree is the news, where they differ is the angle. Wook AI, above, can pull live figures and run the numbers on request — how far $GRCE is from its high, or how this week's coverage compares.
How this analysis was made
Seeking Alpha published it, and Wook filed it under Earnings. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $GRCE. It carried $0.91, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on August 13, 2026. $GRCE has moved -17.59% ($2.16 to $1.78). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.